L-Falergi Dosage/Direction for Use

The film-coated tablet must be taken orally, swallowed whole with liquid and be taken with or without food. It is recommended to take the daily dose in one single intake.
Adults and Children 6 Years and above: The daily recommended dose of is 5 mg (1 film coated tablet). For children aged less than 6 years no adjusted dosage is yet possible.
Elderly: Adjustment of the dose is recommended in elderly patients with moderated to severe renal impairment (see Patients with renal impairment as follows).
Patients with renal impairment: The dosing intervals must be individualised according to renal function. Refer to the table and adjust the dose as indicated. To use this dosing table, an estimate of the patient's creatinine clearance (Cl_cr) in mL/min is needed.
The Cl_cr (mL/min) may be estimated from serum creatinin (mg/dL) determination using the following formula:


Click on icon to see table/diagram/image


Dosing Adjustment for patients with Impaired Renal Function: (See table.)


Click on icon to see table/diagram/image


Patients with hepatic impairment: No dose adjustment is needed in patients with solely hepatic impairment. In patients with hepatic impairment and renal impairment, adjustment of the dose is recommended (see Patients with renal impairment as previously mentioned).
Duration of use: The duration of use depends on the type, duration and course of the complaints. For hay fever 3-6 weeks, and in case of short-term pollen exposure as little as one week, is generally sufficient. Clinical experience with 5 mg Levocetirizine as a film-coated tablet formulation is currently available for a 6-month treatment period. For chronic urticaria and chronic allergic rhinitis, up to one year's clinical experience is available for the racemate, and up to 18 months in patients with pruritus associated with atopic dermatitis.